Navigation Links
Controversial urological issues top EAU's Anniversary Congress in Barcelona
Date:3/15/2010

Arnhem, 15 March 2010 Some of the most controversial issues in urology will be discussed by leading experts during the five-day 25th Annual Congress of the European Association of Urology (EAU) in the Fira Barcelona congress venue in Barcelona (ES). From April 16 to 20, close to 12,000 participants and 3,000 company representatives are expected to gather in one of the world's biggest annual professional meetings in urology.

For its 25th congress, the EAU has prepared a scientific programme that covers a wide range of urological topics including paediatrics, bladder cancer, female urology, renal cell carcinoma, reconstruction and functional urology, benign prostatic obstruction and stones, to name a few.

Urological conditions such as the above affect the lives of millions of people. More than 50% of men over 50 years of age have urological complaints due to benign conditions. More significantly, prostate cancer is the second leading cause of cancer death in the Western world and every year 346,000 new cases of prostate cancer are detected in Europe alone.

The EAU not only aims to raise awareness amongst the public, local and national governments in Europe but also to provide an effective platform for urologists, cancer specialists and other healthcare professionals to discuss pressing issues in healthcare, treatment and research and exchange knowledge and best practices in the clinical setting.

In Barcelona a press event that will discuss 'Prostate cancer screening the debate continues' is scheduled on Saturday 17 April from 12.00 to 13.00 hours. With prominent European cancer experts, the focus will be on the future of European healthcare policies in terms of prostate cancer screening. Leading prostate cancer experts such as Profs. Fritz Schrder (NL) and Lars Holmberg (SE) will discuss the latest developments. The session, to be chaired by Prof. Freddie Hamdy (GB), will also present the patient perspective with Prof. Louis Denis (BE), secretary of the European prostate cancer coalition Europa Uomo, as one of the speakers. Mr. Alojz Peterle (SI), Member of the European Parliament and cancer awareness advocate, will discuss the political views on actions against cancer. Media representatives will be given ample opportunity to ask questions.

The aim of the session is to generate media coverage and thus make the European public and governments more aware of the pressing issues with regard to urological conditions.


'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
European Association of Urology
Source:Eurekalert

Related medicine news :

1. Project Prevention Brings Controversial Sterilization Program to Honolulu
2. First Animated Instructional Oral Sex Video Reaches Mainstream America, Despite the Touchy and Controversial Subject Matter
3. Controversial Autism Study Retracted by Medical Journal
4. Controversial kidney transplant technique could provide lifeline for very ill patients
5. Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate
6. New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall
7. Winnipeg Veterinary Company Pharm-Vet Produces Essential Oil-Infused Mosquito Spray Thats a Welcome and Safe Alternative to Controversial Deet-Based Repellants
8. Blue Cross/Blue Shield Of Massachusetts Introduces Controversial Criteria For Vein Treatment Reimbursement
9. 84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare Competitive Bidding Rule Before April 18 Deadline
10. Homecare Associations Nationwide Urge Policymakers to Rescind Controversial Medicare Competitive Bidding Rule
11. A Decision Beyond Life and Death: Novel Examines Effects of Controversial Procedure on Patients, Their Families and Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Orion, MI (PRWEB) , ... March 24, 2017 ... ... insurance assistance, financial planning, and related services to families and business owners across ... initiative aimed at feeding regional families struggling with financial difficulties. , The Oxford/Orion ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge dentists, Dr. ... for sleep apnea and TMJ at their office. TMJ, or temporomandibular joint disorder, ... obstructive type, is increasingly being treated at dental offices with newly developed procedures ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro ... their partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is ... Ave., Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/23/2017)... & Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... health emergency and now estimates that there could be four million Zika-related cases in ... epidemics to date with numbers of US cases reported per year skyrocketing to an ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , Mar 23, 2017 Research and Markets ... & Trends - Industry Forecast to 2025" report to their ... The ... around 6.9% over the next decade to reach approximately $3.5 billion ... and forecasts for all the given segments on global as well ...
(Date:3/23/2017)... , March 23, 2017  Transportation Insight, a ... an end-to-end supply chain management firm with expertise serving ... Product Solutions Rick Zaffarano was named a ... the Supply Chain by the only publication exclusively dedicated ... food supply chain. "Rick has brought to ...
(Date:3/23/2017)... SILVER SPRING, Md. , March 23, 2017 /PRNewswire-USNewswire/ ... approval to Bavencio (avelumab) for the treatment of adults ... Merkel cell carcinoma (MCC), including those who have not ... for metastatic MCC, a rare, aggressive form of skin ... the most common cancers, patients with a rare form ...
Breaking Medicine Technology: